Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer

This study is ongoing, but not recruiting participants.

Study NCT00181584 Information provided by Massachusetts General Hospital

First Received: September 9, 2005 Last Updated: December 28, 2007 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Primary Completion Date:	February 2006 (Final data collection date for primary outcome measure)